| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| Understanding and Predicting Breast Cancer Events After Treatment | Cardiac MRI | NCT02791581 | Wake Forest University Health Sciences | Recruiting |
| Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil | Donepezil 5 mg, Placebo | NCT02822573 | Wake Forest University Health Sciences | Active, not recruiting |
| Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in... | Informational Intervention, Interview, Medical Chart Review, Questionnaire Administration | NCT02847130 | Children's Oncology Group | Active, not recruiting |
| Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With... | Varenicline, Placebo, Tobacco Cessation Counseling | NCT02856581 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | Retinoid 9cUAB30, Therapeutic Conventional Surgery | NCT02876640 | National Cancer Institute (NCI) | Recruiting |
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts | Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration | NCT02933489 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... | Erlotinib Hydrochloride, Erlotinib | NCT02961374 | National Cancer Institute (NCI) | Active, not recruiting |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration | NCT02965703 | National Cancer Institute (NCI) | Recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Placebo Administration, Questionnaire Administration, Simvastatin | NCT02968810 | National Cancer Institute (NCI) | Recruiting |
| Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate | NCT02993159 | Northwestern University | Recruiting |
Why I Joined a Clinical Trial
At the very first mention of my cancer diagnosis, all I could think of was “How do I beat this…what’s my best course of action?” A clinical trial was the answer. I had never heard of Multiple Myeloma, so I wasn’t real confident that there would be a trial for me to join. I was so relieved when there was. How could one not benefit from constant monitoring and undergoing extra testing? I have done extremely well and have had no setbacks. I don’t know if I would be in the same spot if it weren’t for the trial. I am so thankful for the doctors and researchers that work tirelessly toward a cure.